Literature DB >> 22558478

The histopathological spectrum of human meningiomas.

Thomas Backer-Grøndahl1, Bjørnar H Moen, Sverre H Torp.   

Abstract

Histopathological examination and grading of meningiomas gives valuable prognostic information, although the method is subject for interobserver variability. The aim of this study was to review a large series of human meningiomas in order to examine the frequency of benign (grade I), atypical (grade II), and anaplastic (grade III) forms depending on various WHO classification schemes. In addition, we wanted to describe the frequency of various histopathological features and their mutual correlations. Sections from 196 consecutively treated primary human meningioma patients were revised retrospectively. The established criteria to grade meningiomas, which are also known to be associated with tumorigenesis, were shown to correlate significantly. The number of grade II meningiomas increased when using the WHO 2007 classification (30%) compared with previous editions, mainly due to the definition of brain infiltrating meningiomas as atypical (grade II). bimodal frequency distribution among age groups of females was observed. Continuous revision of histopathological classification systems is required to improve the diagnostic accuracy.

Entities:  

Keywords:  Brain tumors; Clemmesen’s hook; classification; diagnosis; grading

Mesh:

Year:  2012        PMID: 22558478      PMCID: PMC3341686     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  54 in total

1.  Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma.

Authors:  A Gabriella Wernicke; Adam P Dicker; Michal Whiton; Jana Ivanidze; Terry Hyslop; Elizabeth H Hammond; Arie Perry; David W Andrews; Lawrence Kenyon
Journal:  Radiat Oncol       Date:  2010-05-30       Impact factor: 3.481

2.  Carcinoma of the breast; results from statistical research.

Authors:  J CLEMMESEN
Journal:  Br J Radiol       Date:  1948-12       Impact factor: 3.039

3.  Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.

Authors:  Yoo-Jin Kim; Ralf Ketter; Wolf-Ingo Steudel; Wolfgang Feiden
Journal:  Am J Clin Pathol       Date:  2007-07       Impact factor: 2.493

Review 4.  Gray zones in brain tumor classification: evolving concepts.

Authors:  Dimitri Trembath; Christopher Ryan Miller; Arie Perry
Journal:  Adv Anat Pathol       Date:  2008-09       Impact factor: 3.875

5.  Immunocytochemical study of the cellular immune response in meningiomas.

Authors:  M L Rossi; F Cruz Sanchez; J T Hughes; M M Esiri; H B Coakham
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

6.  The meninges in human development.

Authors:  R O'Rahilly; F Müller
Journal:  J Neuropathol Exp Neurol       Date:  1986-09       Impact factor: 3.685

7.  Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas.

Authors:  A E Konstantinidou; N Givalos; H Gakiopoulou; P Korkolopoulou; X Kotsiakis; E Boviatsis; G Agrogiannis; H Mahera; E Patsouris
Journal:  Apoptosis       Date:  2006-12-05       Impact factor: 4.677

8.  Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study.

Authors:  H K Ng; L Chen
Journal:  Histopathology       Date:  1998-07       Impact factor: 5.087

Review 9.  Intracranial meningiomas of atypical (WHO grade II) histology.

Authors:  Leland Rogers; Mark Gilbert; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2010-08-26       Impact factor: 4.130

10.  Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.

Authors:  Stefan Wolfsberger; Soroush Doostkam; Hans-Gerd Boecher-Schwarz; Karl Roessler; Michael van Trotsenburg; Johannes A Hainfellner; Engelbert Knosp
Journal:  Neurosurg Rev       Date:  2004-05-27       Impact factor: 3.042

View more
  58 in total

1.  Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.

Authors:  Varun R Kshettry; Quinn T Ostrom; Carol Kruchko; Ossama Al-Mefty; Gene H Barnett; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-05-24       Impact factor: 12.300

2.  Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.

Authors:  Raymond Y Huang; Wenya Linda Bi; Michael Weller; Thomas Kaley; Jaishri Blakeley; Ian Dunn; Evanthia Galanis; Matthias Preusser; Michael McDermott; Leland Rogers; Jeffrey Raizer; David Schiff; Riccardo Soffietti; Jörg-Christian Tonn; Michael Vogelbaum; Damien Weber; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

3.  Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?

Authors:  Pedro Góes; Bruno Fernandes Oliveira Santos; Fernando Seiji Suzuki; Débora Salles; João Noberto Stávale; Sérgio Cavalheiro; Manoel Antônio de Paiva Neto
Journal:  J Neurooncol       Date:  2017-12-21       Impact factor: 4.130

Review 4.  Benign neck masses showing restricted diffusion: Is there a histological basis for discordant behavior?

Authors:  Abanti Das; Ashu S Bhalla; Raju Sharma; Atin Kumar; Meher Sharma; Shivanand Gamanagatti; Alok Thakar; Suresh Sharma
Journal:  World J Radiol       Date:  2016-02-28

5.  Relationships between tumor microenvironment and clinicopathological parameters in meningioma.

Authors:  Yuanyuan Ding; Lin Qiu; Qian Xu; Lixue Song; Sufang Yang; Tao Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

6.  Immunohistochemical characterization of brain-invasive meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Magnus B Arnli; Kathrin Torseth; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

7.  Diffusion Profiling via a Histogram Approach Distinguishes Low-grade from High-grade Meningiomas, Can Reflect the Respective Proliferative Potential and Progesterone Receptor Status.

Authors:  Georg Alexander Gihr; Diana Horvath-Rizea; Nikita Garnov; Patricia Kohlhof-Meinecke; Oliver Ganslandt; Hans Henkes; Hans Jonas Meyer; Karl-Titus Hoffmann; Alexey Surov; Stefan Schob
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

8.  The influence of age on the histological grading of meningiomas.

Authors:  Jae-Sung Park; Burak Sade; Soichi Oya; Chong Gue Kim; Joung H Lee
Journal:  Neurosurg Rev       Date:  2014-04-29       Impact factor: 3.042

9.  Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.

Authors:  C Leland Rogers; Arie Perry; Stephanie Pugh; Michael A Vogelbaum; David Brachman; William McMillan; Joseph Jenrette; Igor Barani; Dennis Shrieve; Andy Sloan; Joseph Bovi; Young Kwok; Stuart H Burri; Samuel T Chao; Aaron C Spalding; Mitchell S Anscher; Beatrice Bloom; Minesh Mehta
Journal:  Neuro Oncol       Date:  2015-10-22       Impact factor: 12.300

10.  Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer.

Authors:  José Pedro Lavrador; Marta Valente Pinto; Luís Mascarenhas Lemos; Catarina Ribeiro; André Peralta Santos
Journal:  J Neurooncol       Date:  2017-11-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.